The purpose of this study was to investigate the clinical characteristics of chronic hemodialysis (HD) patients with lung cancer who underwent pulmonary resection at the authors' hospital. Subjects were 24 chronic HD patients (1.1%) from among 2178 patients who underwent pulmonary resection for lung cancer at our hospital between December 1994 and March 2009. Subjects included 20 males (83.3%), and mean age was 65.9 years. Twenty-two patients underwent lobectomy, one underwent a wedge resection and one underwent a segmentectomy. Histological diagnoses included squamous cell carcinoma in 12 patients, adenocarcinoma in nine, small cell carcinoma in two and adenosquamous carcinoma in one. The distribution of pathological staging was IA in nine cases, IB in five, IIB in five, IIIA in three, and IIIB in two. There was no operative mortality, and the overall morbidity rate was 58.3%. Disease-free interval was six to 102 months with a median of 54 months, and the five-year survival rate was 43.0%. Cases of pulmonary resection for lung cancer in chronic HD patients were investigated. There were no operative deaths or deaths in hospital, but three patients had serious complications. These data indicate that surgery can be performed safely with appropriate HD and general management in the perioperative period.
Introduction
The number of surgeries for malignant tumors in hemodialysis (HD) patients is currently increasing due to factors, such as age, more widespread use of HD in cancer patients, overall number of long-term dialysis patients, and advances in tumor screening w1x. However, the rate of postoperative complications is high in cases of pulmonary resection in HD patients, and care is needed in perioperative management w2-4x. We conducted a retrospective investigation of clinical characteristics, problems in perioperative management, and prognosis in cases of pulmonary resection for lung cancer in HD patients at our hospital.
Subjects and methods
Subjects were 24 chronic HD patients from among 2178 patients who underwent pulmonary resection for lung cancer at our hospital between December 1994, when the hospital was opened, and March 2009. Peritoneal dialysis patients and patients in whom HD was introduced for postoperative acute renal failure were excluded from the study. Patients included 20 men and four women, with a E-mail address: mktkhm@yahoo.co.jp (M. Takahama).
mean age of 65.9"8.2 years (median age, 66 years). Diseases for which HD was introduced were diabetic nephropathy in 13 patients, chronic glomerulonephritis in six patients, and other conditions in five patients. Twenty patients had a history of smoking, and associated diseases included hypertension in 13 patients, ischemic heart disease in seven, cerebrovascular disorder in three, and emphysema in one. The American Society of Anesthesiologists (ASA) score w4x was 3 in most patients (17 patients) ( 
Numbers in parentheses indicate percentage. cations, and survival period in these patients. Heart failure was considered to be present in cases of poor hemodynamics or if cardiotonic agents had to be administered because of a worsening general condition, and pulmonary fistula was considered to be present in cases of protraction for seven days or more following surgery, or when the patient required chest drainage again after the thoracostomy tube had been removed. Statistical analysis was performed using Dr. SPSS II (SPSS Japan Inc, Tokyo, Japan).
ᮋ
Comparisons between two groups were performed by x -2 test, and survival rate was calculated using the KaplanMeier method.
Results
Preoperative blood values and respiratory function test results are shown in Table 2 . Tumors were discovered due to abnormal chest shadows found during hospital visits for HD in 18 patients, at the initiation of HD in four patients, due to back pain in one patient, and bloody sputum in one patient. A confirmed histological diagnosis was obtained preoperatively in 18 patients.
The operative procedure was lobectomy (LOB) in 22 patients, segmentectomy (SEG) in one patient, and wedge resection (WR) in one patient. In one case, forced expiratory volume in 1 s (FEV ) was 790 ml and FEV % was 1.0 1.0 37.3%, and WR alone was conducted because of low pulmonary function. In one case, because the tumor was located in the peripheral segmentum apicodorsale and its size was 20 mm in a diameter, SEG of S1q2 was conducted. Systemic mediastinal lymph node dissection was performed in 19 patients. Bronchoplasty (BP) was performed in two patients, combined diaphragm (Dia) resection in one patient, and combined chest wall (CW) resection in one patient. Mean operative time was 188 min, and full surface adhesion within the chest cavity was seen in four patients.
Mean blood loss was 257 ml, and transfusions were conducted in three patients (Table 3) . Mean serum potassium level on postoperative day 1 was 4.5 mEqyl. No patients had hyperkalemia that required emergency measures postoperatively, and HD was conducted in all patients on postoperative day 1. The thoracotomy tube was removed after an average of 6.2 days postoperatively. Mean postoperative hospital stay was 15.8"5.3 days (median, 15 days). Postoperative complications after LOB are shown in Table  4 . Although complications occurred in 13 patients, no bronchial stump fistulae were seen and the only serious complication was heart failure in two patients. Two of the three patients with heart failure had a history of heart disease with an ASA score of 3, and so a central venous line was placed during surgery. Prolonged air leakage was the second most common (six patients), and pleurodesis was performed in one patient. Prolonged operating time (over 200 min) (eight cases), amount of blood loss (over 200 ml) (12 cases), requirement of the transfusion (three cases), and extended resection (four cases) did not affect Downloaded from https://academic.oup.com/icvts/article-abstract/11/2/150/705167 by guest on 03 February 2019 Fig. 1 . Actuarial survival rates in patients on hemodialysis who underwent pulmonary resection for lung cancer. Five-year survival rate was 43.0% in all cases (solid line), and 70.0% in p-IA cases (broken line). the incidence of postoperative complications (Ps0.676, 0.746, 0.203, and 0.855, respectively). The morbidity rate was 60.0% in advanced disease (stage IIIA and over) and 58.8% in limited disease (stages I and II) (Ps0.962). Prolonged air leakage and congestive heart failure were seen in the patient who received SEG.
Among histological types, squamous cell carcinoma was the most common, in 12 patients, followed by adenocarcinoma in nine patients. Pathological stage was IA in 10 patients and IB in four patients. Advanced cancer of stage IIIA or more was seen in five patients. In a case of small cell carcinoma (pT2N1M0, IIB), postoperative adjuvant chemotherapy was conducted but the patient experienced heart failure during therapy and died in the fourth month postoperatively. Postoperative adjuvant chemotherapy was not conducted in any other patient.
Follow-up for outcome was possible in 20 of the 24 cases, with postoperative observation periods of four to 102 months and a median of 21 months. Recurrence within one year after surgery was seen in three patients, and in all patients, the disease-free interval was 34.1" 27.0 months (four to 102 months; median, 20 months). Recurrence was seen as intrathoracic lymph node metastasis in three patients, pulmonary metastasis in two patients, brain metastasis in two patients, hepatic metastasis in one patient, and bone metastasis in one patient. In addition, one patient died during postoperative adjuvant chemotherapy, and one patient died of cardiopulmonary arrest following HD in postoperative month 55. The fiveyear survival rate was 43.0% for all patients, and 70.0% for patients with pathological stage IA (ns9) (Fig. 1) .
Discussion
The incidence of malignant tumor is thought to be higher in HD patients than in non-HD patients, but the incidence of lung cancer is thought to be similar in HD patients and non-HD patients w7x. However, the increase is nearly linear in HD patients, and so as HD patients age, the number of HD patients who undergo lung cancer surgery also increases w3x. There is reported to be a high frequency of postoperative complications in HD patients who undergo surgery for lung cancer w1, 2x. Problems that arise from patients' preoperative state include undernutrition, water and electrolyte abnormalities, anemia, tendency to bleed, immunoincompetence, increased protein catabolism and decreased synthesis ability, vascular lesions, glucose intolerance, and delayed wound healing.
Kellerman recommends compensation to maintain preoperative Ht at 30%, serum potassium levels at 4.0 mEqyl or below, serum BUN at 60 mgyml, and serum Cr at about 6 mgyml w8x. However, in the present study, there were no patients who needed transfusion or albumin replacement immediately before surgery. To avoid risk of postoperative bleeding, HD using ultra-short acting nafamostat mesilate (Futhan ) is reported to be effective w9x, and we also ᮋ conducted HD using nafamostat mesilate until the thoracostomy tube was withdrawn.
Monitoring of hemodynamics with a central venous line or pulmonary artery catheter is thought to be necessary because of the possibility of heart failure from increased heart strain caused by pulmonary vascular bed reduction as a result of pulmonary resection or pulmonary edema from excessive infusion w1, 2x. However, in patients who had an ASA score of 2 or higher, indicating a relatively good general condition, and well controlled electrolyte and water balance, postoperative hemodynamics could be managed safely, even without invasive monitoring, such as a central venous line w4x. Complicating postoperative heart failure was seen in two patients who received LOB (9.1%). These were patients who had a history of heart failure, had heart disease, or had low pulmonary function. In patients with low pulmonary function, intraoperative and postoperative management should be performed while monitoring with a central venous line, and active administration of cardiotonic agents is thought to be beneficial. In our limited experience, the incidence of postoperative complications was not affected by peri-and postoperative conditions.
Lung cancer is often discovered early in HD patients because of regular chest X-rays. In the present investigation, cancer was discovered when the patient was asymptomatic in 22 cases (91.7%). Of the total 2178 patients who have undergone lung cancer surgery at our hospital, the pathological stage was p-IA in 644 patients (32.7%) and p-IB in 430 patients (21.8%). No significant differences were seen in a comparison of HD patients and non-HD patients, with HDynon-HDs36.4%y32.7% (Ps0.401) in stage p-IA, and HDynon-HDs18.2%y21.9% (Ps0.274) in stage p-IB. It would, therefore, be difficult to claim that discovery was substantially earlier in HD patients.
A histological feature in the present study was that 50.0% of cases were squamous cell carcinoma. Of the 2178 patients who have undergone lung cancer surgery at our hospital, 695 (31.9%) had squamous cell carcinoma. There were significantly more HD patients with squamous cell carcinoma (P-0.05), and this is thought to be a feature of lung cancer in HD patients. In our study, 83.3% of patients were smokers, and thus many were expected to develop squamous cell carcinoma. We performed surgery for the two patients with small cell lung carcinoma, as we could not obtain a definitive diagnosis for these patients before surgery. We subsequently performed postoperative adjuvant chemotherapy in one patient, but the other patient refused adjuvant chemotherapy. The operative indications for HD patients with small cell lung carcinoma thus require circumspection and remain controversial.
In HD patients who undergo surgery for malignant tumors, the prognosis is considered to be poor because of decreased immune function and death from other diseases w3, 7x. Excluding one patient who died from another disease thought to be related to HD and one patient who was lost to follow-up in the present study, prognosis was poor in stage p-IA patients, with a five-year survival rate of 70.0%. In stage p-IA, recurrent-type metastasis was seen in one patient with pulmonary metastasis and one patient with recurrence of intrathoracic lymph node metastasis, both occurring within one year. Although this may be why the five-year survival rate was low, there are no reports with regard to long-term prognosis in large numbers of patients.
Chemotherapy was not performed in the present cases of recurrent metastasis, and this may be the reason for poor prognosis w10x. Maisonneuve et al. reported that renal disease as an underlying condition in HD patients may affect prognosis w7x. However, death was tumor-related in three of the five patients in the report by Tsuchida et al. w1x , and in our investigation, there were no cases of death from other diseases in p-IA patients. Although early detection by the dialysis physician is important in improving prognosis, long-term cooperation between the dialysis physician and respiratory surgeon is necessary in postoperative management.
Cases of pulmonary resection for lung cancer in chronic HD patients were investigated. There were no operative deaths or deaths in hospital. Surgery can be performed safely with appropriate HD and general management in the perioperative period. By histological type, the greatest number of patients had squamous cell carcinoma, and in cases with p-IA, the five-year survival rate was poor at 70.0%.
